Table 3.

Analysis of selected studies on the administered regimens with the inclusion of rebamipide.

Rebamipide-Containing Regimen	Studies
Dual therapy (PPI + amoxicillin)	Saita et al. [26]; Hahm et al. [27]; Nebiki et al. [28]; Kato et al. [29]; Fujioka et al. [32];
Triple therapy (PPI + amoxicillin + clarithromycin/metronidazole)	Kimura et al. [30]; Lee et al. [31]; Dicheva et al. [35]; Andreev et al. [36]
Triple therapy with bismuth (PPI + amoxicillin + clarithromycin + bismuth tripotassium dicitrate)	Simanenkov et al. [33]
Concomitant therapy (PPI + amoxicillin + clarithromycin + metronidazole)	Kim et al. [34]